A nanoparticles-based delivery of mRNAs encoding interferon regulatory factor 5 and its activating kinase IKKβ promisingly reprogram TAMs into M1-like phenotype, consequently inducing anti-tumor immunity and promoting tumor regression in vitro. Here, IKBKB is linked to neoplasm.